Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/2810
Title: | Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk? | Authors: | Demir, B. Aktas, S. Altun, Z. Ercetin, P. Olgun, N. |
Publisher: | Wiley-Blackwell | Abstract: | [Abstract Not Available] | Description: | 41st FEBS Congress on Molecular and Systems Biology for a Better Life -- SEP 03-08, 2016 -- Kusadasi, TURKEY | URI: | https://hdl.handle.net/20.500.14365/2810 | ISSN: | 1742-464X 1742-4658 |
Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.